ADXSD
Advaxis, Inc.

26,617
Loading...
Loading...
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. Its lead candidates are the oral gamma secretase inhibitor, AL102, for desmoid tumors, and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company was founded on June 5, 1987 and is headquartered in Monmouth Junction, NJ.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Advaxis, Inc.?
What is the 52-week high for Advaxis, Inc.?
What is the 52-week low for Advaxis, Inc.?
What is Advaxis, Inc. stock price today?
What was Advaxis, Inc. stock price yesterday?
What is the 50-day moving average of Advaxis, Inc.?

Latest ADXSD News

View
No ADXSD news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.